Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-26

Clinical Trial Update: Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Roxadustat for anemia in patients with diabetic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roxadustat (roxadustat)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Diabetic Kidney Disease, Anemia | Phase 4 | Status: COMPLETED